What, exactly, do we mean when we say “global studies?”
“That’s the central question,” Niklaus Steiner, the director of the Center for Global Initiatives at the University of North Carolina at Chapel Hill, said when pressed by an assistant provost in his audience who asked, “What is the intellectual justification for global studies? What do you bring that’s new?”
“What’s the central answer?”
“I see hands going up,” Steiner said, smiling, not-so-deftly dodging the question but clearing the way for further discussion on the emerging field and its place in the academy.
Submitted by Andy Guess on February 21, 2008 - 4:00am
As a battleground for the animal liberation movement, the University of California at Los Angeles has weathered threats, intimidation and property damage directed against several of its researchers over the past few years. Today -- two weeks after a firebomb went off at the same professor's house that in October was flooded with a garden hose -- the university moved beyond law enforcement, the bully pulpit and security reinforcements and filed a lawsuit against three groups and five individuals.
Submitted by Andy Guess on February 22, 2008 - 4:00am
Ask anyone with an M.B.A.: Business school provides an ideal environment to network, learn management principles and gain access to jobs. Professors there use a mix of scholarly expertise and business experience to teach theory and practice, while students prepare for the life of industry: A simple formula that serves the school, the students and the corporations that recruit them.
When Robert M. Gates, the secretary of defense, announced plans for the Minerva Consortia last month, he surprised many social scientists. Gates proposed the creation of a series of university-based consortiums to support research on questions of importance to the military, but said that the research would be unclassified and would not be subject to political litmus tests.
Conflicts of interest, always an emotional topic, returned to the headlines this week as Sen. Charles Grassley, a longtime critic of the drug industry's potential influence on research, released new evidence that prominent Harvard University scientists had failed to disclose much of their outside income from pharmaceutical companies over the past eight years.